Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.
BACKGROUND: Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patients undergoing hematopoietic stem cell transplantation (HSCT) have not been studied extensively. We aimed to evaluate platelet and RBC transfusion efficacy by measuring the platelet corrected count in...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3365127?pdf=render |
id |
doaj-689b13795dea4cc0a53a934189dea56e |
---|---|
record_format |
Article |
spelling |
doaj-689b13795dea4cc0a53a934189dea56e2020-11-25T02:15:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0175e3691210.1371/journal.pone.0036912Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation.Xi ZhangYanni XiaoQian RanYao LiuQianbi DuanHuiling DuanXingde YeZhongjun LiBACKGROUND: Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patients undergoing hematopoietic stem cell transplantation (HSCT) have not been studied extensively. We aimed to evaluate platelet and RBC transfusion efficacy by measuring the platelet corrected count increment and the hemoglobin increment, respectively, 24 h after transfusion in 105 patients who received HSCT. METHODOLOGY/PRINCIPAL FINDINGS: Using retrospective analysis, we studied whether factors, including gender, time of transplantation, the compatibility of ABO group between HSC donors and recipients, and autologous or allogenic transplantation, influence the efficacy of blood component transfusion. We found that the infection rate of HSCT patients positively correlated with the transfusion amount, and the length of stay in the laminar flow room was associated with transfusion. We found that platelet transfusion performed during HSCT showed significantly better efficacy than that performed before HSCT. The effect of platelet transfusion in auto-transplantation was significantly better than that in allo-transplantation. The efficacy of RBC transfusion during HSCT was significantly lower than that performed before HSCT. The efficacy of RBC transfusion in auto-transplantation was significantly higher than that in allo-transplantation. Allo-transplantation patients who received HSCs from compatible ABO groups showed significantly higher efficacy during both platelet and RBC transfusion. CONCLUSIONS: We conclude that the efficacy of platelet and RBC transfusions does not correlate with the gender of patients, while it significantly correlates with the time of transplantation, type of transplantation, and ABO compatibility between HSC donors and recipients. During HSCT, the infection rate of patients positively correlates with the transfusion amount of RBCs and platelets. The total volume of RBC units transfused positively correlates with the length of the patients' stay in the laminar flow room.http://europepmc.org/articles/PMC3365127?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xi Zhang Yanni Xiao Qian Ran Yao Liu Qianbi Duan Huiling Duan Xingde Ye Zhongjun Li |
spellingShingle |
Xi Zhang Yanni Xiao Qian Ran Yao Liu Qianbi Duan Huiling Duan Xingde Ye Zhongjun Li Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation. PLoS ONE |
author_facet |
Xi Zhang Yanni Xiao Qian Ran Yao Liu Qianbi Duan Huiling Duan Xingde Ye Zhongjun Li |
author_sort |
Xi Zhang |
title |
Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation. |
title_short |
Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation. |
title_full |
Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation. |
title_fullStr |
Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation. |
title_full_unstemmed |
Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation. |
title_sort |
clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2012-01-01 |
description |
BACKGROUND: Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patients undergoing hematopoietic stem cell transplantation (HSCT) have not been studied extensively. We aimed to evaluate platelet and RBC transfusion efficacy by measuring the platelet corrected count increment and the hemoglobin increment, respectively, 24 h after transfusion in 105 patients who received HSCT. METHODOLOGY/PRINCIPAL FINDINGS: Using retrospective analysis, we studied whether factors, including gender, time of transplantation, the compatibility of ABO group between HSC donors and recipients, and autologous or allogenic transplantation, influence the efficacy of blood component transfusion. We found that the infection rate of HSCT patients positively correlated with the transfusion amount, and the length of stay in the laminar flow room was associated with transfusion. We found that platelet transfusion performed during HSCT showed significantly better efficacy than that performed before HSCT. The effect of platelet transfusion in auto-transplantation was significantly better than that in allo-transplantation. The efficacy of RBC transfusion during HSCT was significantly lower than that performed before HSCT. The efficacy of RBC transfusion in auto-transplantation was significantly higher than that in allo-transplantation. Allo-transplantation patients who received HSCs from compatible ABO groups showed significantly higher efficacy during both platelet and RBC transfusion. CONCLUSIONS: We conclude that the efficacy of platelet and RBC transfusions does not correlate with the gender of patients, while it significantly correlates with the time of transplantation, type of transplantation, and ABO compatibility between HSC donors and recipients. During HSCT, the infection rate of patients positively correlates with the transfusion amount of RBCs and platelets. The total volume of RBC units transfused positively correlates with the length of the patients' stay in the laminar flow room. |
url |
http://europepmc.org/articles/PMC3365127?pdf=render |
work_keys_str_mv |
AT xizhang clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation AT yannixiao clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation AT qianran clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation AT yaoliu clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation AT qianbiduan clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation AT huilingduan clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation AT xingdeye clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation AT zhongjunli clinicalobservationoffactorsintheefficacyofbloodcomponenttransfusioninpatientsfollowinghematopoieticstemcelltransplantation |
_version_ |
1724898070570729472 |